Arcutis Biotherapeutics Director Howard G. Welgus Reports Disposal of Common Shares Worth $127,325.04

• Arcutis Biotherapeutics director Howard G. Welgus sold 4,728 common shares at $26.93 each on October 15, 2026.
• Welgus exercised stock options for 822 shares at $6.5223, 1,018 shares at $7.51 and 2,254 shares at $8.63 that day.
• His direct common stock holdings totaled 35,207 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-066331), on October 19, 2026, and is solely responsible for the information contained therein.